4-Hydroxyphenylpyruvate dioxygenase inhibitor
4-Hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors (HPPD inhibitors) are a class of herbicides that prevent growth in plants by blocking 4-Hydroxyphenylpyruvate dioxygenase, an enzyme in plants that breaks down the amino acid tyrosine into molecules that are then used by plants to create other molecules that plants need. This process of breakdown (catabolism) and the production of new molecules from the results (biosynthesis), is something that all living things do. HPPD inhibitors were first brought to market in 1980, although their mechanism of action was not understood until the late 1990s. At the time, they were primarily used in the Japanese rice production industry, but since the late 1990s have been used in Europe and North America for corn, soybeans, and cereals. Since the 2000s, they have become more important as weeds have become more resistant to glyphosate and other herbicides. Genetically modified crops which are resistant to HPPD inhibitors are under development. There is a pharmaceutical drug on the market, nitisinone, that was originally under development as an herbicide as a member of this class and is used to treat an orphan disease, type I tyrosinemia.
HPPD inhibitors can be classified into three fundamental chemical frameworks: pyrazolones, triketones, and diketonitriles. The triketone class is based on a chemical that certain plants make in self-defense called leptospermone; the class was developed by scientists at companies that eventually became part of Syngenta. Bayer CropScience has also been active in developing new HPPD inhibitors.